Cabotib 20MG Tablet (30’s) is a pharmaceutical product containing Cabozantinib as its active ingredient, specifically formulated to treat certain types of cancer. This medication is primarily indicated for patients with advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer) who have previously undergone treatment. Cabozantinib works by inhibiting multiple receptor tyrosine kinases, which are involved in tumor growth and progression, thereby helping to slow down the spread of cancer cells. Each tablet contains 20 mg of Cabozantinib, and the packaging typically includes 30 tablets, making it convenient for patients to manage their treatment regimen. The drug is designed to be taken orally, and its effectiveness is enhanced when used as part of a comprehensive cancer treatment plan, which may include other therapies and supportive care.